Enhancer ID: | E_02_0511 |
Species: | human |
Position : | chr6:16296402-16298402 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Spinocerebellar ataxia type 1 (sca1), amyotrophic lateral sclerosis (als), huntington's disease (hd), parkinson's disease, multiple system atrophy (msa) |
Pubmed ID: | 30043530 |
Enhancer experiment: | Rotarod analysis, quantitative analysis of immunofluorescent staining, Western blot, RT qPCR, statistical analysis |
Enhancer experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
Target gene : | ATXN1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
TF name : | -- |
TF experiment: | Rotarod analysis,Quantitative Analysis of immunofluorescent staining,Western blot,RT-qPCR,???? |
TF experiment description: | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
Enhancer function : | Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Spinocerebellar ataxia type 1 (SCA1) is a fatal, dominantly inherited neurodegenerative disease caused by the expansion of CAG repeats in the Ataxin-1 (ATXN1) gene. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|